Article abstract-Objective: To investigate the role of apoptosis in acute quadriplegic myopathy. Background: Acute quadriplegic myopathy is a muscular disease characterized by diffuse flaccid weakness occurring in patients with severe systemic illness and exposure to corticosteroids or neuroblocking agents. Myofiber atrophy and thick filament loss are the distinguishing pathologic features on muscle biopsy. Increased calpains expression and lysosomal and nonlysosomal proteolytic pathways have been claimed as possible pathogenic factors. Nevertheless, the mechanisms leading to myofiber atrophy and thick filament loss need further investigation. Patients and methods: The expression of ubiquitin and proapoptotic proteases as well as DNA fragmentation in muscle biopsies from three patients with acute quadriplegic myopathy were studied. Results: All patients exhibited an important overexpression of caspases, calpain, cathepsin B, and ubiquitin, and the presence of numerous apoptotic nuclei in over 70% of myofibers. Conclusions: These data suggest that apoptosis mediated by proteolytic proteases may play a role in the pathogenesis of acute quadriplegic myopathy. NEUROLOGY 2000;55:854-858 Acute quadriplegic myopathy (AQM) occurs in critically ill patients and is characterized by acute, generalized, and prolonged flaccid weakness. It is multifactorial and can be associated with exposure to corticosteroids and neuroblocking agents, sepsis, intensive care, multiorgan failure, severe pulmonary disorders, and major surgery. Muscle biopsy typically shows muscle fiber atrophy with selective loss of myosin filaments. The pathogenic mechanisms leading to acute muscle damage are still obscure. The overexpression of ubiquitin and proteases such as calpains and lysosomal enzymes has been claimed to explain muscle protein degradation.
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The pathogenic mechanisms leading to acute muscle damage are still obscure. The overexpression of ubiquitin and proteases such as calpains and lysosomal enzymes has been claimed to explain muscle protein degradation. [2] [3] [4] Necrosis is rare in AQM, and calpain, cathepsin B, and ubiquitin have a role in some apoptotic pathways. Therefore, we postulated that muscle fiber shrinkage and protein breakdown could be mediated by apoptosis through caspases and caspaseindependent proteases that may be involved in a specific proteolytic cascade leading to DNA fragmentation.
To verify this hypothesis, we studied the presence of apoptosis-like features such as protease expression and DNA fragmentation in muscle biopsies from three patients with AQM and eight patients affected by various neurogenic disorders with prominent myofiber atrophy.
Patients. Patient 1.
A 66-year-old man with insulindependent diabetes mellitus, chronic obstructive pulmonary disease, and atrial fibrillation was admitted to the hospital because of diffuse myalgia, articular pain, and fever and received IV methylprednisolone 20 mg/d for about 3 weeks. Three months before admission he had a long-standing fever and rheumatism of unknown cause treated with aspirin and prednisone for several weeks. One month before admission he had undergone partial colon resection for diverticulitis that was followed by sepsis. After 2 weeks of IV methylprednisolone he developed a severe generalized weakness and muscle wasting. Deep tendon reflexes were very weak. Serum creatine kinase (CK) levels were one-tenth normal and electromyography showed diffuse myopathic changes. A left deltoid muscle biopsy was performed 2 weeks after the onset of the muscle weakness. Steroids were rapidly reduced and discontinued. The patient was placed on a high-protein diet and started a slow recovery.
Patient 2. A 66-year-old man was treated for a left humerus fracture; after surgery he developed a pulmonary infection followed by sepsis. A bone marrow biopsy, performed because of severe thrombocytopenia, showed a pattern of severe myelodysplasia. Fifteen days after surgery he experienced acute respiratory distress syndrome and was put on mechanical ventilation for 12 days in the intensive care unit. For 2 weeks he received methylprednisolone 300 mg/d that was tapered and discontinued in the third week because of a rapidly progressive and severe muscle weakness. At the time of our examination he was quadriplegic and his limb muscles were markedly hypotrophic. Deep tendon reflexes were weak. CK levels were below normal. Electromyography revealed a myopathy. After discontinuation of methylprednisolone, the patient slowly started to recover muscle strength. A left quadriceps muscle biopsy was performed 20 days after the onset of muscle weakness.
Patient 3. An 84-year-old man with a history of insulin-dependent diabetes mellitus, chronic obstructive pulmonary disease, and pulmonary emphysema was admitted for severe asthma. He had been given long-term prednisone, theophylline, and ␤ 2 -agonists for the lung dis-ease. On admission he exhibited respiratory acidosis and metabolic alkalosis. He was given IV methylprednisolone 40 mg/d for 2 weeks and developed a marked weakness of the axial and lower limb muscles with moderate weakness of upper limbs. Steroids were then tapered and discontinued. Deep tendon reflexes and serum CK levels were normal. Electromyography showed myopathic features in both upper and lower limbs. A right quadriceps muscle biopsy was performed 20 days after the onset of weakness.
Methods. We performed terminal deoxynucleotidyl transferase-mediated of UTP nick end labelling (TUNEL), electron microscopy, and immunohistochemistry for apoptosis-related proteases, interleukin-coverting enzyme (ICE), and caspase 3, cathepsin B, calpain, and ubiquitin in diagnostic muscle biopsies from three patients with AQM and 13 control patients. As experimental controls we selected eight patients with neurogenic disorders associated with features of acute myofiber atrophy (two with motor neuron disease, one with proximal spinal muscular atrophy (SMA) type I, two with SMA type II, two with SMA type III, and one with axonal neuropathy) and five patients with normal biopsy results (they underwent biopsy because of myalgias and hyper-CKemia). In the three patients with AQM, we also performed biochemical assays to measure acid maltase activities.
TUNEL and immunohistochemistry. The TUNEL technique was used for detection of nuclear DNA fragmentation in situ. Frozen muscle sections from patients and control subjects were incubated under the same coverslip with TUNEL reaction mixture and incorporated fluorescein-dUTP was detected by using alkaline phosphatase-conjugated antifluorescein antibodies according to the manufacturer's instruction (In Situ Cell Death Detection Kit, Boehringer, Mannheim, Germany). The count of TUNEL-positive nuclei was performed in at least 100 muscle fibers per section. Unfixed 10-m muscle sections adjacent to those analyzed by means of TUNEL were processed for immunocytochemistry as follows: sections were dried at room temperature, fixed in cold acetone and pretreated with 0.3% H 2 O 2 in phosphate-buffered saline (PBS) to quench the endogenous peroxidase activity, rinsed in PBS, and incu- bated with 10% normal serum (goat, rabbit, or sheep, depending on the secondary antibodies used) for 60 minutes to mask nonspecific adsorption sites. Sections were then incubated for 1 hour at room temperature with one of the following antibodies: rabbit polyclonal against human ICE (Santa Cruz, diluted 1:100; Santa Cruz, CA), goat polyclonal antihuman caspase 3 (Santa Cruz, diluted 1:200), mouse monoclonal antihuman cathepsin B (Calbiochem, diluted 1:50; Cambridge, MA), mouse monoclonal antihuman or m-calpain small subunit (Chemicon, diluted 1:100), or mouse monoclonal antihuman ubiquitin (Chemicon, diluted 1:100). After several rinses in PBS, the sections were incubated with the appropriate biotinylated secondary antibodies (goat antirabbit, rabbit antigoat, or sheep antimouse IgG) washed in PBS and then incubated with the avidin-biotin peroxidase complex according to the manufacturer's instructions (Vectastain ABC, Vector Laboratories, Burlingame, CA). Peroxidase staining was obtained by incubating the sections in 0.075% DAB (3,3-diaminobenzioline) and 0.002% H 2 O 2 in 50 mM Tris buffer (pH 7.6) for 10 minutes.
Electron microscopy. Muscle samples were fixed and processed by standard methods, and examined with a Philips 208S electron microscope (Philips Medical Systems, Best, the Netherlands).
Results. Myofiber atrophy and thick filament loss ( figure  1, A and B) were present in all patients with AQM. There was no selective myofiber type atrophy. Only rare necrotic and regenerating fibers were detected in Patients 1 and 2, whereas Patient 3 had numerous regenerating fibers. TUNEL-positive myonuclei were observed in 70% to 90% of muscle fibers (figure 1, C through E). Immunostaining for caspases (ICE and caspase 3), cathepsin B, calpain, and ubiquitin was present in the majority of hypotrophic myofibers and in a few nonatrophic fibers. Caspases, cathepsin B, and calpain showed an intense and diffuse cytoplasmic staining (figure 2, A through D) while ubiquitin immunolabelling was as diffuse but less intense (not shown). TUNEL-positive nuclei were also observed in hypotrophic myofibers from patients with some neurogenic disorders ( figure 3A) . In particular, TUNEL-positive nuclei were detected in about 50% of myofibers in patients with SMA I, 30% to 50% of myofibers in axonal neuropathy, and only in rare myofibers in motor neuron disease, SMA II, and SMA III. ICE, cathepsin B, and calpain showed a weak signal in a few hypotrophic fibers from patients with axonal neuropathy, motor neuron disease, and SMA III ( figure 3 , B through D), and no protease staining was observed in patients with SMA I and II. The five normal control subjects had negative results for both TUNEL ( figure 1, F) and immunohistochemistry.
Electron microscopy demonstrated numerous atrophic fibers with vast areas of thick filament loss, relative preservation of Z disks and actin filaments, and morphologically abnormal nuclei containing highly condensed chromatin (figure 1B) .
Biochemical assay demonstrated a marked increase of acid maltase activities in all patients with AQM (Patient 1: 36.5 nmol ⅐ mU/min/g; Patient 2: 56.9 nmol ⅐ mU/min/g; nmol methylumbelliferone/min/g Patient 3: 51.11 nmol ⅐ mU/min/g; normal: 7.52 Ϯ 1.86 nmol ⅐ mU/min/g nmol methylumbelliferone/min/g).
Discussion
. Apoptosis plays an important role during embryogenesis and in the control of normal tissue homeostasis. 5, 6 Dysregulation of apoptosis has been implicated in a variety of disorders such as cancer, neurodegenerative diseases, heart disease, stroke, and autoimmune disease. 7 Moreover, apoptotic features have been described in human muscle pathology in the atrophic fibers of neurogenic muscle atrophies and in mitochondrial disorders. 8, 9 We now show the presence of apoptotic features in muscle fibers of three patients with AQM.
Many exogenous factors are able to trigger apoptosis: pH variations, hypoxia, oxidative stress, stress proteins, inflammation, chemotherapeutic agents, and glucocorticoids. 5, 6 Our patients had metabolic imbalances because of sepsis, hypoxia, and diabetes mellitus. They had also undergone long-term IV corticosteroid treatment, and one had received neuroblocking agents during anesthesia. Glucocorticoids have a proteolytic action and inhibit protein synthesis. 4 They are also important inducers of apoptotic cell death in some cell types. Dexamethasone, in fact, has been demonstrated to cause myopathic damage and to activate programmed cell death in myoblasts under hyperosmolar stress, blocking the protective action and anabolic effects of insulin-like growth factor 1.
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Caspases are the major players of the apoptotic proteolytic machinery; they are able to initiate (e.g., ICE) and execute (e.g., caspase 3) a pathogenic cascade leading to endonuclease-mediated DNA fragmentation.
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The chaperone protein ubiquitin and the caspaseindependent proteases calpain and cathepsin B are involved, at least in some cell types, in the apoptotic pathway. 12 Calpains, which are neutral Ca 2ϩ -dependent cysteine proteases, are implicated in apoptosis in vivo and in dexamethasone-induced apoptosis in cellular systems. 13, 14 The ATP-dependent ubiquitinproteasome pathway has a prominent, recognized role in muscle protein degradation, has been suggested to play a role in apoptosis, and is activated by glucocorticoids and catabolic conditions. 4,15 Cathepsin B, an acidic lysosomal protease, has a caspase-processing activity (it activates caspases, e.g., ICE, from inactive forms) and is able to induce nuclear apoptosis in vitro. 16 The overexpression of ubiquitin and these proteases in the muscle of our patients with myosin degradation supports previous evidence of calpain-, cathepsin B-, and ubiquitin-mediated proteolysis in AQM. 2, 3 The observation of increased cathepsin B expression in muscle fibers of our patients with AQM, along with augmented acid maltase activity, suggests that lysosomal activation plays an important role in the apoptotic process.
Caspases, cathepsin B, calpain, and ubiquitin seem to have a synergistic effect in AQM as they are localized in hypotrophic myofibers with a similar staining pattern (figure 2). The contemporary presence of TUNEL-positive myonuclei within muscle fibers with increased expression of caspases and caspase-independent proteases suggests that both muscle fiber atrophy and myosin degradation leading to thick filament loss may be due to the apoptotic cascade. Moreover, the specificity of our findings in AQM is supported by the observation that in neurogenic diseases, despite of the presence of a variable number of TUNEL-positive nuclei in atrophic muscle fibers, only rare hypotrophic myofibers showed a faint staining for ICE, cathepsin B, and calpain (figure 3) . Thus, muscle fiber atrophy in patients with AQM is accompanied by apoptotic features and increased protease expression probably triggered by exogenous chemical factors, whereas apoptotic, hypotrophic myofibers in patients with neurogenic diseases lack protease overexpression.
